Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease [2]

Journal of the American Geriatrics Society

Volumn 49, Issue 7, 2001, Pages 1003-1004

  Mangoni, Arduino A ^a,b,c   Ouldred, Emma ^a,b,c   Swif, Cameron G ^a,b,c   Jackson, Stephen H D ^a,b,c   Draper, Ruth P ^a,b,c   Sherwood, Roy A ^a,b,c   Lambert Hammill, Michelle ^a,b,c   Wierzbicki, Anthony S ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

AGING; BLOOD PRESSURE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART INFARCTION; HEART PROTECTION; HUMAN; LETTER; RIGIDITY; RISK FACTOR; STROKE;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MYOCARDIAL INFARCTION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0034864663     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2001.49196.x     Document Type: Letter

References (6)

1. Homocysteine and vascular disease
2. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
3. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
4. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia
5. 6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial
6. Clinical value of aortic pulse-wave velocity measurement